2024
Novel multi-modal methodology to investigate placebo response in major depressive disorder
Cusin C, Dillon D, Belleau E, Normandin M, Petibon Y, El-Fakri G, Dhaynaut M, Hooker J, Kaptchuk T, McKee M, Hayden E, Meyer A, Jahan A, Origlio J, Ang Y, Brunner D, Kang M, Long Y, Fava M, Pizzagalli D. Novel multi-modal methodology to investigate placebo response in major depressive disorder. Journal Of Affective Disorders 2024, 368: 1-7. PMID: 39233242, DOI: 10.1016/j.jad.2024.08.226.Peer-Reviewed Original ResearchPlacebo responseDepressive disorderRates of placebo responseMesocorticolimbic dopaminergic pathwayExpectation of rewardAntidepressant responseMesolimbic systemReward circuitryNeurobiological underpinningsNeurobiological mechanismsDopaminergic activityDopaminergic systemPlacebo respondersSymptom reductionDopaminergic pathwaysMulti-modal methodologyPlacebo phenomenonPsychological constructsTreatment developmentMDDPlacebo-controlledClinical trialsDouble-blindRewardDesigning clinical trials
2021
Exploring Gender Differences in the Placebo Response to Major Depressive Disorder (MDD) Using Neuroimaging Techniques
Jahan A, Dillon D, Petibon Y, Meyer A, Normandin M, Belleau E, Alpert N, Fakhri G, Hooker J, Crowley D, Cusin C, Pizzagalli D, Fava M. Exploring Gender Differences in the Placebo Response to Major Depressive Disorder (MDD) Using Neuroimaging Techniques. Biological Psychiatry 2021, 89: s171-s172. DOI: 10.1016/j.biopsych.2021.02.438.Peer-Reviewed Original Research